Product catalog antigen listed by alphabetic starting with H
| Items 1 to 100 of 893 total | 9 Page(s): |
Protein
| Catalog No. | Species | Presentation | Purity | Source | |||
|---|---|---|---|---|---|---|---|
| 10-288-21964F | H/ACA ribonucleoprotein complex subunit 1 antigen | ||||||
| Human | Purified | 90% | E. coli | 0.1 mg / --- | |||
| GenWay Biotech Inc. | |||||||
| 10-288-21964F-50 | H/ACA ribonucleoprotein complex subunit 1 antigen | ||||||
| Human | Purified | 90% | E. coli | 50 µg / --- | |||
| GenWay Biotech Inc. | |||||||
| H00083740-Q01-10 | H2AFB3 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00083740-Q01-25 | H2AFB3 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00094239-P01-10 | H2AFV antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00094239-P01-25 | H2AFV antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003015-P01-10 | H2AFZ antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003015-P01-25 | H2AFZ antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003020-P01-10 | H3F3A antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003020-P01-25 | H3F3A antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003021-P01-10 | H3F3B antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003021-P01-25 | H3F3B antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003021-P02-10 | H3F3B antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003021-P02-25 | H3F3B antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00009563-Q01-10 | H6PD antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00009563-Q01-25 | H6PD antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| HA11-P | HA Epitope Tag (YPYDVPDYA) peptide antigen | ||||||
| Purified | - | Synthetic | 0.1 mg / --- | ||||
| Alpha Diagnostic Intl. Inc. | |||||||
| HA15-R | HA-tag -Protein control antigen | ||||||
| Purified | E. coli | 0.1 mg / --- | |||||
| Alpha Diagnostic Intl. Inc. | |||||||
| H00003026-Q01-10 | HABP2 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003026-Q01-25 | HABP2 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00057531-Q01-10 | HACE1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00057531-Q01-25 | HACE1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003028-Q01-10 | HADH2 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003028-Q01-25 | HADH2 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003032-Q01-10 | HADHB antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003032-Q01-25 | HADHB antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003033-P01-02 | HADHSC antigen | ||||||
| Human | in vitro transl. | 2 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003033-P01-10 | HADHSC antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003033-P01-25 | HADHSC antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003033-Q01-10 | HADHSC antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003033-Q01-25 | HADHSC antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003029-Q01-10 | HAGH antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003029-Q01-25 | HAGH antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| 10-288-22161F | Hairy/enhancer-of-split related with YRPW motif 1 antigen | ||||||
| Human | Purified | 95% | E. coli | 0.1 mg / --- | |||
| GenWay Biotech Inc. | |||||||
| 10-288-22161F-50 | Hairy/enhancer-of-split related with YRPW motif 1 antigen | ||||||
| Human | Purified | 95% | E. coli | 50 µg / --- | |||
| GenWay Biotech Inc. | |||||||
| 10-288-22333F | Hairy/enhancer-of-split related with YRPW motif-like antigen | ||||||
| Human | Purified | 95% | E. coli | 0.1 mg / --- | |||
| GenWay Biotech Inc. | |||||||
| 10-288-22333F-50 | Hairy/enhancer-of-split related with YRPW motif-like antigen | ||||||
| Human | Purified | 95% | E. coli | 50 µg / --- | |||
| GenWay Biotech Inc. | |||||||
| H00057817-P01-10 | HAMP antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00057817-P01-25 | HAMP antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00010238-P01-10 | HAN11 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00010238-P01-25 | HAN11 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00001404-P01-10 | HAPLN1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00001404-P01-25 | HAPLN1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00060484-Q01-10 | HAPLN2 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00060484-Q01-25 | HAPLN2 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00145864-P01-10 | HAPLN3 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00145864-P01-25 | HAPLN3 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00404037-Q01-10 | HAPLN4 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00404037-Q01-25 | HAPLN4 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| BA311 | Haptoglobin antigen | ||||||
| Human | Purified | >95% | Plasma | 5 mg / --- | |||
| Acris Antibodies GmbH | |||||||
| P119-1 | Haptoglobin antigen | ||||||
| Human | >96% | Serum | 1 mg / ask | ||||
| Scipac Ltd. | |||||||
| H00003035-P01-02 | HARS antigen | ||||||
| Human | in vitro transl. | 2 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003035-P01-10 | HARS antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003035-P01-25 | HARS antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003035-Q01-10 | HARS antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003035-Q01-25 | HARS antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00023438-Q01-10 | HARSL antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00023438-Q01-25 | HARSL antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003037-Q01-10 | HAS2 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003037-Q01-25 | HAS2 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003038-P01-10 | HAS3 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003038-P01-25 | HAS3 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00008520-P01-02 | HAT1 antigen | ||||||
| Human | in vitro transl. | 2 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00008520-P01-10 | HAT1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00008520-P01-25 | HAT1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00008520-Q01-10 | HAT1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00008520-Q01-25 | HAT1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00026762-P01-02 | HAVCR1 antigen | ||||||
| Human | in vitro transl. | 2 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00026762-P01-10 | HAVCR1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00026762-P01-25 | HAVCR1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00026762-Q01-10 | HAVCR1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00026762-Q01-25 | HAVCR1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00084868-P01-10 | HAVCR2 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00084868-P01-25 | HAVCR2 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00010456-P01-10 | HAX1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00010456-P01-25 | HAX1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003039-Q01-10 | HBA1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003039-Q01-25 | HBA1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003040-P01-10 | HBA2 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003040-P01-25 | HBA2 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003043-Q01-10 | HBB antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003043-Q01-25 | HBB antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003046-P01-10 | HBE1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003046-P01-25 | HBE1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00001839-P01-10 | HBEGF antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00001839-P01-25 | HBEGF antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003047-P01-10 | HBG1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003047-P01-25 | HBG1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003047-Q01-10 | HBG1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003047-Q01-25 | HBG1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003047-P02-10 | HBG1 (P02) antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003047-P02-25 | HBG1 (P02) antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00081689-P01-10 | HBLD2 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00081689-P01-25 | HBLD2 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003049-Q01-10 | HBQ1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003049-Q01-25 | HBQ1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| 8HS7-3 (0.5mg) | HBsAg (recombinant, adr subtype) antigen | ||||||
| Purified | >98% | Yeast | 0.5 mg / --- | ||||
| HyTest Ltd. | |||||||
| 8HS7-3 (1mg) | HBsAg (recombinant, adr subtype) antigen | ||||||
| Purified | >98% | Yeast | 1 mg / --- | ||||
| HyTest Ltd. | |||||||
| 8HS7-2 (0.5mg) | HBsAg (recombinant, adw subtype) antigen | ||||||
| Purified | >98% | Yeast | 0.5 mg / --- | ||||
| HyTest Ltd. | |||||||
| 8HS7-2 (1mg) | HBsAg (recombinant, adw subtype) antigen | ||||||
| Purified | >98% | Yeast | 1 mg / --- | ||||
| HyTest Ltd. | |||||||
| Items 1 to 100 of 893 total | 9 Page(s): |

